Literature DB >> 2786351

Monitoring of the inflammatory response in early peritonitis.

U Schöffel1, T Zeller, M Lausen, G Ruf, E H Farthmann.   

Abstract

The inflammatory response which is similar in all forms of peritonitis was recorded by determining the levels of parameters shown to represent the activation state of plasmatic and cellular systems as well as the inhibitory capacity of the plasma. In a selected series of patients with different underlying diseases, blood sampling was started at the time of admission when the clinical finding of an acute abdomen led to emergency laparotomy. Depending upon the duration of the illness and the severity of the peritonitis, a significant increase in fibrinopeptide A and of C3a could be detected within a few hours, which was followed by an increase in the elastase alpha-1-proteinase inhibitor complex. Differences due to variable cause could not be found. There was a striking correlation between the preoperative values of these three parameters and the postoperative course of the patients. Additionally, there was a significant enhancement of an endothelial proliferation-inhibiting capacity in the serums of the lethal group, whereas endotoxin could only be detected in trace amounts in four patients with intraabdominal infection in the preoperative period.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786351     DOI: 10.1016/0002-9610(89)90701-0

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  2 in total

1.  The Equine PeptideAtlas: a resource for developing proteomics-based veterinary research.

Authors:  Louise Bundgaard; Stine Jacobsen; Mette A Sørensen; Zhi Sun; Eric W Deutsch; Robert L Moritz; Emøke Bendixen
Journal:  Proteomics       Date:  2014-02-16       Impact factor: 3.984

2.  Effect of human bowel wall distension on translocation of indigenous bacteria and endotoxins.

Authors:  U Schoeffel; D Jaeger; K Pelz; R Salm; E H Farthmann
Journal:  Dig Dis Sci       Date:  1994-03       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.